Khaled H. Barakat
Edmonton, AB, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 93 publications
Residue-level insights into SGLT2 inhibition and Nav1.5 selectivity of gliflozin derivatives: A molecular dynamics and pharmacophore-guided study.
Journal: Journal of molecular graphics & modelling
Published: May 20, 2026
AI-MedCraft: A Strategy-Driven AI Platform for Multi-Objective Molecular Design.
Journal: Journal of chemical information and modeling
Published: March 27, 2026
Late INa as a Therapeutic Target: New Strategies, Computational Modelling, Drug Development, and Clinical Translation.
Journal: Medicinal research reviews
Published: November 17, 2025
Multiscale computational analysis reveals enhanced allosteric modulation of Nav1.5 by dual binding of dapagliflozin and ertugliflozin.
Journal: Scientific reports
Published: September 12, 2025
Structural insights into the binding modes of SHP2 allosteric inhibitors.
Journal: In silico pharmacology
Published: September 09, 2025
Epigenetic control of telomeric RNA maintains heterochromatin in telomerase-driven cancers.
Journal: Signal transduction and targeted therapy
Published: August 13, 2025
Indirect Modeling of Post-Prandial Intestinal Lymphatic Uptake of Halofantrine Using PBPK Approaches: Limitations and Implications.
Journal: Pharmaceutics
Published: August 12, 2025
A chemoproteomic strategy for identifying protein covalent binding targets of clozapine: An approach for advancing clozapine toxicity research.
Journal: Toxicology letters
Published: June 26, 2025
Therapeutic potential of TIM-3 inhibition in cancer, viral infections, and autoimmune disorders.
Journal: The international journal of biochemistry & cell biology
Published: October 30, 2024
Designing a multi-neoantigen vaccine for melanoma: Integrating immunoinformatics and biophysics methods.
Journal: Computers in biology and medicine
Published: August 04, 2024
Angiostatin-a novel SARS-CoV-2 inhibitor and biomarker underlying COVID-19 pathophysiology.
Journal: Journal of thrombosis and haemostasis : JTH
Published: July 26, 2024
Cardioprotective effect of 19,20-epoxydocosapentaenoic acid (19,20-EDP) in ischaemic injury involves direct activation of mitochondrial sirtuin 3.
Journal: Cardiovascular research
Published: July 25, 2024
Last Updated: 09/26/2026